key: cord-0709224-q36c4z1t authors: De Franceschi, Lucia; Costa, Enrico; Dima, Francesco; Morandi, Matteo; Olivieri, Oliviero title: Glucose-6-phosphate dehydrogenase deficiency associated hemolysis in COVID-19 patients treated with hydroxychloroquine/chloroquine: new case reports coming out date: 2020-08-13 journal: European Journal of Internal Medicine DOI: 10.1016/j.ejim.2020.08.015 sha: 3ad20a34b807bca861b0478e639d47ddc5c3859b doc_id: 709224 cord_uid: q36c4z1t nan . In addition, hemoglobinuria is a hallmark of intravascular hemolysis, which characterizes drug induced acute hemolysis in G6PD patients [6] . Otherwise, drug induced hemolytic anemia in patients with healthy red cells is general an extravascular hemolysis without hemoglobinuria. Italy is an endemic area for G6PD deficiency [6] . Our patient was suspected for G6PD deficiency based on previous hemolytic events recorded in patient history. To fully answer the question raised by Afra et al., we have evaluated G6PD activity in our patients at 8 weeks after hospital discharge. As expected we found G6PD deficiency with normal complete blood count analysis and normal reticulocyte count (43.500 retics/uL). Collectively our results and the post-recovery determination of G6PD support the link between acute hemolysis and HCQ/CQ treatment in COVID-19 patients. No funding for this study The authors have nothing to disclose Linking hydroxychloroquine to hemolysis in a "suspected" glucose 6 phosphate dehydrogenase deficient patient with COVID-19 infection-a critical appraisal Acute hemolysis by hydroxycloroquine was observed in G6PD-deficient patient with severe COVD-19 related lung injury Glucose-6-phosphate dehydrogenase deficiency-associated hemolysis and methemoglobinemia in a COVID-19 patient treated with chloroquine COVID-19 infection and treatment with hydroxychloroquine cause severe haemolysis crisis in a patient with glucose-6-phosphate dehydrogenase deficiency A case report of serious haemolysis in a glucose-6-phosphate dehydrogenase-deficient COVID-19 patient receiving hydroxychloroquine Glucose-6-phosphate dehydrogenase deficiency ☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work We would like to thank prof MD Cappellini for the fruitful discussion.